Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul;42(4):432-436.
doi: 10.1111/scd.12689. Epub 2021 Dec 13.

Oral findings and healthcare management in Shashi-Pena syndrome

Dua'a Alqaisi  1 , Yazan Hassona  1   2
Affiliations
Case Reports

Oral findings and healthcare management in Shashi-Pena syndrome

Dua'a Alqaisi et al. Spec Care Dentist. 2022 Jul.

Abstract

Shashi Pena syndrome (SHAPNS) is a newly recognized and rare neurodevelopmental disorder with unique phenotypic features. The syndrome is caused by truncating variants in ASXL2 gene. To date, there are only seven documented cases in scientific literature, but oral and dental findings are sparsely reported. Here, we present a new case of SHAPNS and describe the oro-dental findings and oral healthcare management of affected patients.

Keywords: ASXL, ASXL2, manifestations, oral, Pena, rare disease, Shashi; syndrome.

PubMed Disclaimer

References

REFERENCES

    1. Shashi V, Pena LD, Kim K, et al. De Novo truncating variants in ASXL2 are associated with a unique and recognizable clinical phenotype. Am J Hum Genet. 2016;99(4):991-999.
    1. Cuddapah VA, Dubbs HA, Adang L, et al. Understanding the phenotypic spectrum of ASXL-related disease: ten cases and a review of the literature. Am J Med Genet A. 2021;185:1700-1711.
    1. Katoh M. Functional and cancer genomics of ASXL family members. Br J Cancer. 2013;109:299-306.
    1. Yu KP, Luk HM, Fung JLF, Chung BH, Lo IF. Further expanding the clinical phenotype in Bainbridge-Ropers syndrome and dissecting genotype-phenotype correlation in the ASXL3 mutational cluster regions. Eur J Med Genet. 2021;64:104107.
    1. Katoh M. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine. Expert Rev Proteomics. 2015;12:317-328.

Publication types

LinkOut - more resources